Evicenter
Vraylar (cariprazine) in Major depressive disorder
Manufacturer
AbbVie Inc.
Prescribing information
Vraylar (opens in a new tab)
Questions
32
Last updated

All questions

Clinical trials: Vraylar (cariprazine) in major depressive disorder

6 questions · 3 sources

Study results

How effective is Vraylar added to an antidepressant for depression?

Note: The 2 to 4.5 mg/day range in the 8-week trial extends above the 3 mg/day maximum recommended dosage for MDD.

Does Vraylar improve anhedonia in depression?

Note: The page presents the subscale results as a figure; the captured text holds the heading and the analysis qualifications quoted here.

Does Vraylar reduce anxiety symptoms in depression (HAM-A)?

Note: The page presents the HAM-A results as a figure; the captured text holds the heading and the analysis qualifications quoted here.

Does Vraylar improve quality of life in depression (SF-12v2)?

Note: The page presents the SF-12v2 results as a figure; the captured text holds the heading and the analysis qualifications quoted here.

Clinical trials

How were the Vraylar trials in depression (MDD) designed?

Which antidepressants were patients taking in the Vraylar MDD trials?